Terms: = Prostate cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Treatment
55 results:
1. ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression.
Xu H; Li YF; Yi XY; Zheng XN; Yang Y; Wang Y; Liao DZ; Zhang JP; Tan P; Xiong XY; Jin X; Gong LN; Qiu S; Cao DH; Li H; Wei Q; Yang L; Ai JZ
Mil Med Res; 2023 Dec; 10(1):64. PubMed ID: 38082365
[TBL] [Abstract] [Full Text] [Related]
2. FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway.
Wang M; Huang W
Biochem Pharmacol; 2023 Dec; 218():115893. PubMed ID: 37890593
[TBL] [Abstract] [Full Text] [Related]
3. PSMC4 promotes prostate carcinoma progression by regulating the CBX3-EGFR-PI3K-AKT-mTOR pathway.
Liu K; Zhang S; Gong Y; Zhu P; Shen W; Zhang Q
J Cell Mol Med; 2023 Aug; 27(16):2437-2447. PubMed ID: 37436074
[TBL] [Abstract] [Full Text] [Related]
4. A rare case of prostate cancer initially presented by disseminated intravascular coagulation-related subdural hemorrhage.
Shafie M; Shahmohamadi E; Hadizadeh A; Hasanzadeh A; Gholampour G; Parsa S
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1868. PubMed ID: 37435692
[TBL] [Abstract] [Full Text] [Related]
5. PARP1 negatively regulates transcription of BLM through its interaction with HSP90AB1 in prostate cancer.
Huang M; Chen L; Guo Y; Ruan Y; Xu H
J Transl Med; 2023 Jul; 21(1):445. PubMed ID: 37415147
[TBL] [Abstract] [Full Text] [Related]
6. Bony structure enhanced synthetic CT generation using Dixon sequences for pelvis MR-only radiotherapy.
Liang X; Yen A; Bai T; Godley A; Shen C; Wu J; Meng B; Lin MH; Medin P; Yan Y; Owrangi A; Desai N; Hannan R; Garant A; Jiang S; Deng J
Med Phys; 2023 Dec; 50(12):7368-7382. PubMed ID: 37358195
[TBL] [Abstract] [Full Text] [Related]
7. Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after prostate cancer Surgery.
Téllez C; Szczesniewski J; Virseda-Chamorro M; Arance I; Angulo JC
Curr Oncol; 2023 Apr; 30(4):4153-4165. PubMed ID: 37185429
[TBL] [Abstract] [Full Text] [Related]
8. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.
Kong D; Ye C; Zhang C; Sun X; Wang F; Chen R; Xiao G; He S; Xu J; Rao X; Ai J; Gao X; Li H; Su L
J Exp Clin Cancer Res; 2023 Feb; 42(1):45. PubMed ID: 36759880
[TBL] [Abstract] [Full Text] [Related]
9. SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination.
Lv T; He D; Zhang X; Guo X; Li Z; Zhang A; Fan B; Wang Z
Aging (Albany NY); 2022 Dec; 14(24):10050-10066. PubMed ID: 36566018
[TBL] [Abstract] [Full Text] [Related]
10. Hsa_circ_0094606 promotes malignant progression of prostate cancer by inducing M2 polarization of macrophages through PRMT1-mediated arginine methylation of ILF3.
Zhang Y; Wang K; Yang D; Liu F; Xu X; Feng Y; Wang Y; Zhu S; Gu C; Sheng J; Hu L; Xu B; Lu YJ; Feng N
Carcinogenesis; 2023 May; 44(1):15-28. PubMed ID: 36394342
[TBL] [Abstract] [Full Text] [Related]
11. Rosin Derivative IDOAMP Inhibits prostate cancer Growth via Activating RIPK1/RIPK3/MLKL Signaling Pathway.
Xu H; Zeng X; Wei X; Xue Z; Chen N; Zhu W; Xie W; He Y
Oxid Med Cell Longev; 2022; 2022():9325973. PubMed ID: 35965682
[TBL] [Abstract] [Full Text] [Related]
12. CircRNA circ_0006156 inhibits the metastasis of prostate cancer by blocking the ubiquitination of S100A9.
Zhang Y; Liu F; Feng Y; Xu X; Wang Y; Zhu S; Dong J; Zhao S; Xu B; Feng N
Cancer Gene Ther; 2022 Nov; 29(11):1731-1741. PubMed ID: 35760899
[TBL] [Abstract] [Full Text] [Related]
13. The alkalinizing, lysosomotropic agent ML-9 induces a pH-dependent depletion of ER Ca
Kerkhofs M; Vervloessem T; Luyten T; Stopa KB; Chen J; Vangheluwe P; Bultynck G; Vervliet T
Biochim Biophys Acta Mol Cell Res; 2022 Oct; 1869(10):119308. PubMed ID: 35710019
[TBL] [Abstract] [Full Text] [Related]
14. Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.
Chen L; Song Y; Hou T; Li X; Cheng L; Li Y; Xing Y
J Exp Clin Cancer Res; 2022 Jun; 41(1):194. PubMed ID: 35659274
[TBL] [Abstract] [Full Text] [Related]
15. Weight loss via a low-carbohydrate diet improved the intestinal permeability marker, zonulin, in prostate cancer patients.
Lin PH; Howard L; Freedland SJ
Ann Med; 2022 Dec; 54(1):1221-1225. PubMed ID: 35486445
[TBL] [Abstract] [Full Text] [Related]
16. Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signaling.
Saxena N; Beraldi E; Fazli L; Somasekharan SP; Adomat H; Zhang F; Molokwu C; Gleave A; Nappi L; Nguyen K; Brar P; Nikesitch N; Wang Y; Collins C; Sorensen PH; Gleave M
EMBO Mol Med; 2021 May; 13(5):e13427. PubMed ID: 33709547
[TBL] [Abstract] [Full Text] [Related]
17. First referral to an integrated onco-palliative care program: a retrospective analysis of its timing.
Barth C; Colombet I; Montheil V; Huillard O; Boudou-Rouquette P; Tlemsani C; Alexandre J; Goldwasser F; Vinant P
BMC Palliat Care; 2020 Mar; 19(1):31. PubMed ID: 32164672
[TBL] [Abstract] [Full Text] [Related]
18. Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches.
Deep G; Jain A; Kumar A; Agarwal C; Kim S; Leevy WM; Agarwal R
Mol Carcinog; 2020 Mar; 59(3):323-332. PubMed ID: 31943365
[TBL] [Abstract] [Full Text] [Related]
19. Methods for Evaluation of a Snake Venom-Derived Disintegrin in Animal Models of Human cancer.
Swenson SD; Silva-Hirschberg C; Markland FS
Methods Mol Biol; 2020; 2068():185-204. PubMed ID: 31576529
[TBL] [Abstract] [Full Text] [Related]
20. Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer.
Shen Y; Cao J; Liang Z; Lin Q; Wang J; Yang X; Zhang R; Zong J; Du X; Peng Y; Zhang J; Shi J
Cell Commun Signal; 2019 May; 17(1):50. PubMed ID: 31122254
[TBL] [Abstract] [Full Text] [Related]
[Next]
